Skip to main content
. 2020 Oct 26;25(21):4940. doi: 10.3390/molecules25214940

Figure 7.

Figure 7

DHN-II-84 and DHN-III-14 decrease antiapoptotic markers in neuroendocrine cancer cells. Protein levels of MCL-1 and XIAP were evaluated by Western blotting after 48 h of treatment. MCL-1, myeloid cell leukemia-1; XIAP, X-linked inhibitor of apoptosis protein. Both antiapoptotic markers decreased in MZ-CRC-1 and H727 cell lines. Only DHN-II-84 treatment in BON cell line decreased XIAP. Densitometry graphs of MCL-1 and XIAP protein levels normalized to beta-actin band intensity levels. Relative density levels shown after treatment.